Tikun Olam-Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd (TFSHF) Stock Competitors & Peer Comparison
See (TFSHF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TFSHF | $1.50 | +0.00% | 0 | N/A | N/A | N/A |
| ALBHF | $0.62 | +0.00% | 10B | 62.00 | $0.01 | N/A |
| ALBBY | $12.15 | +0.00% | 9.8B | 48.60 | $0.25 | N/A |
| MSMKF | $21.20 | +0.00% | 8.4B | 23.56 | $0.90 | +1.42% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| CLCGY | $41.87 | -0.64% | 5B | 29.69 | $1.41 | +0.55% |
| RGEDF | $27.17 | +0.00% | 5B | 7.99 | $3.40 | +4.89% |
| RADLY | $2.61 | -6.45% | 4.7B | 21.31 | $0.13 | +2.00% |
| GEDSF | $24.85 | +0.00% | 4.5B | 10.71 | $2.32 | +5.89% |
| CSMYF | $46.06 | +0.00% | 3.7B | 19.77 | $2.33 | +1.03% |
Stock Comparison
TFSHF vs ALBHF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ALBHF has a market cap of 10B. Regarding current trading prices, TFSHF is priced at $1.50, while ALBHF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALBHF's P/E ratio is 62.00. In terms of profitability, TFSHF's ROE is N/A, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, TFSHF and ALBHF have similar daily volatility (0.00).Check ALBHF's competition here
TFSHF vs ALBBY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ALBBY has a market cap of 9.8B. Regarding current trading prices, TFSHF is priced at $1.50, while ALBBY trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALBBY's P/E ratio is 48.60. In terms of profitability, TFSHF's ROE is N/A, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, TFSHF and ALBBY have similar daily volatility (0.00).Check ALBBY's competition here
TFSHF vs MSMKF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, MSMKF has a market cap of 8.4B. Regarding current trading prices, TFSHF is priced at $1.50, while MSMKF trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MSMKF's P/E ratio is 23.56. In terms of profitability, TFSHF's ROE is N/A, compared to MSMKF's ROE of +0.11%. Regarding short-term risk, TFSHF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check MSMKF's competition here
TFSHF vs DCHPF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, TFSHF is priced at $1.50, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, TFSHF's ROE is N/A, compared to DCHPF's ROE of N/A. Regarding short-term risk, TFSHF and DCHPF have similar daily volatility (0.00).Check DCHPF's competition here
TFSHF vs CLCGY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, CLCGY has a market cap of 5B. Regarding current trading prices, TFSHF is priced at $1.50, while CLCGY trades at $41.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CLCGY's P/E ratio is 29.69. In terms of profitability, TFSHF's ROE is N/A, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, TFSHF is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check CLCGY's competition here
TFSHF vs RGEDF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, RGEDF has a market cap of 5B. Regarding current trading prices, TFSHF is priced at $1.50, while RGEDF trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RGEDF's P/E ratio is 7.99. In terms of profitability, TFSHF's ROE is N/A, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, TFSHF is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check RGEDF's competition here
TFSHF vs RADLY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, RADLY has a market cap of 4.7B. Regarding current trading prices, TFSHF is priced at $1.50, while RADLY trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RADLY's P/E ratio is 21.31. In terms of profitability, TFSHF's ROE is N/A, compared to RADLY's ROE of +0.18%. Regarding short-term risk, TFSHF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check RADLY's competition here
TFSHF vs GEDSF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, TFSHF is priced at $1.50, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, TFSHF's ROE is N/A, compared to GEDSF's ROE of +0.19%. Regarding short-term risk, TFSHF and GEDSF have similar daily volatility (0.00).Check GEDSF's competition here
TFSHF vs CSMYF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, CSMYF has a market cap of 3.7B. Regarding current trading prices, TFSHF is priced at $1.50, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, TFSHF's ROE is N/A, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, TFSHF is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check CSMYF's competition here
TFSHF vs WLCGF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, TFSHF is priced at $1.50, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, TFSHF's ROE is N/A, compared to WLCGF's ROE of +0.06%. Regarding short-term risk, TFSHF and WLCGF have similar daily volatility (0.00).Check WLCGF's competition here
TFSHF vs SDGCF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, TFSHF is priced at $1.50, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, TFSHF's ROE is N/A, compared to SDGCF's ROE of +0.12%. Regarding short-term risk, TFSHF and SDGCF have similar daily volatility (0.00).Check SDGCF's competition here
TFSHF vs SHPPF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SHPPF has a market cap of 3B. Regarding current trading prices, TFSHF is priced at $1.50, while SHPPF trades at $148.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SHPPF's P/E ratio is -73.38. In terms of profitability, TFSHF's ROE is N/A, compared to SHPPF's ROE of -0.10%. Regarding short-term risk, TFSHF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SHPPF's competition here
TFSHF vs SGIPF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, TFSHF is priced at $1.50, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, TFSHF's ROE is N/A, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, TFSHF is less volatile compared to SGIPF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SGIPF's competition here
TFSHF vs TSUSF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, TSUSF has a market cap of 2.7B. Regarding current trading prices, TFSHF is priced at $1.50, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, TFSHF's ROE is N/A, compared to TSUSF's ROE of +0.06%. Regarding short-term risk, TFSHF is less volatile compared to TSUSF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check TSUSF's competition here
TFSHF vs SAEYY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SAEYY has a market cap of 2.4B. Regarding current trading prices, TFSHF is priced at $1.50, while SAEYY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SAEYY's P/E ratio is -58.75. In terms of profitability, TFSHF's ROE is N/A, compared to SAEYY's ROE of -0.10%. Regarding short-term risk, TFSHF is less volatile compared to SAEYY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SAEYY's competition here
TFSHF vs HTSUY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, HTSUY has a market cap of 2B. Regarding current trading prices, TFSHF is priced at $1.50, while HTSUY trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HTSUY's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, TFSHF is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check HTSUY's competition here
TFSHF vs BJTRF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, BJTRF has a market cap of 542.8M. Regarding current trading prices, TFSHF is priced at $1.50, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, TFSHF's ROE is N/A, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, TFSHF is less volatile compared to BJTRF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check BJTRF's competition here
TFSHF vs ZRSEF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ZRSEF has a market cap of 508.5M. Regarding current trading prices, TFSHF is priced at $1.50, while ZRSEF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ZRSEF's P/E ratio is -2.14. In terms of profitability, TFSHF's ROE is N/A, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, TFSHF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check ZRSEF's competition here
TFSHF vs NVACF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, TFSHF is priced at $1.50, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NVACF's P/E ratio is 31.60. In terms of profitability, TFSHF's ROE is N/A, compared to NVACF's ROE of +0.02%. Regarding short-term risk, TFSHF is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check NVACF's competition here
TFSHF vs HTPRF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, HTPRF has a market cap of 12.1M. Regarding current trading prices, TFSHF is priced at $1.50, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, TFSHF's ROE is N/A, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, TFSHF and HTPRF have similar daily volatility (0.00).Check HTPRF's competition here
TFSHF vs PNPL Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, PNPL has a market cap of 10.2M. Regarding current trading prices, TFSHF is priced at $1.50, while PNPL trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas PNPL's P/E ratio is -14.00. In terms of profitability, TFSHF's ROE is N/A, compared to PNPL's ROE of +0.54%. Regarding short-term risk, TFSHF and PNPL have similar daily volatility (0.00).Check PNPL's competition here
TFSHF vs ETBI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ETBI has a market cap of 9M. Regarding current trading prices, TFSHF is priced at $1.50, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ETBI's P/E ratio is -0.40. In terms of profitability, TFSHF's ROE is N/A, compared to ETBI's ROE of +0.00%. Regarding short-term risk, TFSHF is less volatile compared to ETBI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check ETBI's competition here
TFSHF vs FFLWF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, TFSHF is priced at $1.50, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, TFSHF's ROE is N/A, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, TFSHF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check FFLWF's competition here
TFSHF vs RLLVF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, RLLVF has a market cap of 5.3M. Regarding current trading prices, TFSHF is priced at $1.50, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, TFSHF's ROE is N/A, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, TFSHF is less volatile compared to RLLVF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check RLLVF's competition here
TFSHF vs HEWA Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, HEWA has a market cap of 4.5M. Regarding current trading prices, TFSHF is priced at $1.50, while HEWA trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HEWA's P/E ratio is -3.50. In terms of profitability, TFSHF's ROE is N/A, compared to HEWA's ROE of -0.02%. Regarding short-term risk, TFSHF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check HEWA's competition here
TFSHF vs GABLF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, TFSHF is priced at $1.50, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GABLF's P/E ratio is -0.04. In terms of profitability, TFSHF's ROE is N/A, compared to GABLF's ROE of +2.91%. Regarding short-term risk, TFSHF and GABLF have similar daily volatility (0.00).Check GABLF's competition here
TFSHF vs SYDRF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SYDRF has a market cap of 2.3M. Regarding current trading prices, TFSHF is priced at $1.50, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, TFSHF's ROE is N/A, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, TFSHF is less volatile compared to SYDRF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SYDRF's competition here
TFSHF vs IWINF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, TFSHF is priced at $1.50, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IWINF's P/E ratio is -0.06. In terms of profitability, TFSHF's ROE is N/A, compared to IWINF's ROE of -0.21%. Regarding short-term risk, TFSHF and IWINF have similar daily volatility (0.00).Check IWINF's competition here
TFSHF vs LGNZZ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, LGNZZ has a market cap of 1.5M. Regarding current trading prices, TFSHF is priced at $1.50, while LGNZZ trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNZZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check LGNZZ's competition here
TFSHF vs NUTTQ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, TFSHF is priced at $1.50, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, TFSHF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check NUTTQ's competition here
TFSHF vs CNBI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, TFSHF is priced at $1.50, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CNBI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to CNBI's ROE of +0.17%. Regarding short-term risk, TFSHF is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check CNBI's competition here
TFSHF vs RADCQ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, TFSHF is priced at $1.50, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, TFSHF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check RADCQ's competition here
TFSHF vs LGNYZ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, LGNYZ has a market cap of 505.5K. Regarding current trading prices, TFSHF is priced at $1.50, while LGNYZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNYZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check LGNYZ's competition here
TFSHF vs AEGY Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, TFSHF is priced at $1.50, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas AEGY's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to AEGY's ROE of +0.00%. Regarding short-term risk, TFSHF and AEGY have similar daily volatility (0.00).Check AEGY's competition here
TFSHF vs IPAH Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, IPAH has a market cap of 273.6K. Regarding current trading prices, TFSHF is priced at $1.50, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IPAH's P/E ratio is -0.05. In terms of profitability, TFSHF's ROE is N/A, compared to IPAH's ROE of -0.82%. Regarding short-term risk, TFSHF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check IPAH's competition here
TFSHF vs SCRCQ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SCRCQ has a market cap of 141.1K. Regarding current trading prices, TFSHF is priced at $1.50, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, TFSHF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SCRCQ's competition here
TFSHF vs KIARF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, KIARF has a market cap of 131.8K. Regarding current trading prices, TFSHF is priced at $1.50, while KIARF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas KIARF's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to KIARF's ROE of -1.47%. Regarding short-term risk, TFSHF is less volatile compared to KIARF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check KIARF's competition here
TFSHF vs FOGCF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, TFSHF is priced at $1.50, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FOGCF's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, TFSHF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check FOGCF's competition here
TFSHF vs MDIN Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, TFSHF is priced at $1.50, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MDIN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to MDIN's ROE of +0.36%. Regarding short-term risk, TFSHF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check MDIN's competition here
TFSHF vs OXIHF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, OXIHF has a market cap of 65.7K. Regarding current trading prices, TFSHF is priced at $1.50, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas OXIHF's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, TFSHF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check OXIHF's competition here
TFSHF vs LGNDZ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, LGNDZ has a market cap of 57.9K. Regarding current trading prices, TFSHF is priced at $1.50, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNDZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check LGNDZ's competition here
TFSHF vs IMMB Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, IMMB has a market cap of 57.5K. Regarding current trading prices, TFSHF is priced at $1.50, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IMMB's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to IMMB's ROE of -0.09%. Regarding short-term risk, TFSHF and IMMB have similar daily volatility (0.00).Check IMMB's competition here
TFSHF vs AXMP Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, AXMP has a market cap of 40.9K. Regarding current trading prices, TFSHF is priced at $1.50, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas AXMP's P/E ratio is 0.05. In terms of profitability, TFSHF's ROE is N/A, compared to AXMP's ROE of N/A. Regarding short-term risk, TFSHF and AXMP have similar daily volatility (0.00).Check AXMP's competition here
TFSHF vs LGNXZ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, LGNXZ has a market cap of 40.5K. Regarding current trading prices, TFSHF is priced at $1.50, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNXZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check LGNXZ's competition here
TFSHF vs DECN Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, TFSHF is priced at $1.50, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas DECN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to DECN's ROE of +0.00%. Regarding short-term risk, TFSHF and DECN have similar daily volatility (0.00).Check DECN's competition here
TFSHF vs HADV Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, HADV has a market cap of 32.2K. Regarding current trading prices, TFSHF is priced at $1.50, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HADV's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to HADV's ROE of +0.83%. Regarding short-term risk, TFSHF and HADV have similar daily volatility (0.00).Check HADV's competition here
TFSHF vs SPPH Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, TFSHF is priced at $1.50, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SPPH's P/E ratio is -0.03. In terms of profitability, TFSHF's ROE is N/A, compared to SPPH's ROE of -0.50%. Regarding short-term risk, TFSHF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check SPPH's competition here
TFSHF vs WPHM Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, WPHM has a market cap of 23.2K. Regarding current trading prices, TFSHF is priced at $1.50, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas WPHM's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to WPHM's ROE of -1.56%. Regarding short-term risk, TFSHF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check WPHM's competition here
TFSHF vs CAFS Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, CAFS has a market cap of 19.9K. Regarding current trading prices, TFSHF is priced at $1.50, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CAFS's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to CAFS's ROE of +1.94%. Regarding short-term risk, TFSHF and CAFS have similar daily volatility (0.00).Check CAFS's competition here
TFSHF vs TSTS Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, TFSHF is priced at $1.50, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas TSTS's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to TSTS's ROE of +2.32%. Regarding short-term risk, TFSHF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check TSTS's competition here
TFSHF vs IXSBF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, TFSHF is priced at $1.50, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, TFSHF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check IXSBF's competition here
TFSHF vs VIAP Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, TFSHF is priced at $1.50, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas VIAP's P/E ratio is -0.05. In terms of profitability, TFSHF's ROE is N/A, compared to VIAP's ROE of +0.65%. Regarding short-term risk, TFSHF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check VIAP's competition here
TFSHF vs ALST Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ALST has a market cap of 10.1K. Regarding current trading prices, TFSHF is priced at $1.50, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALST's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to ALST's ROE of +0.13%. Regarding short-term risk, TFSHF and ALST have similar daily volatility (0.00).Check ALST's competition here
TFSHF vs HBOSF Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, TFSHF is priced at $1.50, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, TFSHF's ROE is N/A, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, TFSHF and HBOSF have similar daily volatility (0.00).Check HBOSF's competition here
TFSHF vs PXYN Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, TFSHF is priced at $1.50, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas PXYN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to PXYN's ROE of -0.20%. Regarding short-term risk, TFSHF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check PXYN's competition here
TFSHF vs IYXI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, IYXI has a market cap of 5.3K. Regarding current trading prices, TFSHF is priced at $1.50, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IYXI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to IYXI's ROE of +1.71%. Regarding short-term risk, TFSHF and IYXI have similar daily volatility (0.00).Check IYXI's competition here
TFSHF vs NEWG Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, TFSHF is priced at $1.50, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NEWG's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to NEWG's ROE of +0.40%. Regarding short-term risk, TFSHF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check NEWG's competition here
TFSHF vs FSPM Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, TFSHF is priced at $1.50, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FSPM's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to FSPM's ROE of N/A. Regarding short-term risk, TFSHF and FSPM have similar daily volatility (0.00).Check FSPM's competition here
TFSHF vs GRPI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, TFSHF is priced at $1.50, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GRPI's P/E ratio is -0.02. In terms of profitability, TFSHF's ROE is N/A, compared to GRPI's ROE of +0.09%. Regarding short-term risk, TFSHF and GRPI have similar daily volatility (0.00).Check GRPI's competition here
TFSHF vs OMHE Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, OMHE has a market cap of 983. Regarding current trading prices, TFSHF is priced at $1.50, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas OMHE's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to OMHE's ROE of +0.73%. Regarding short-term risk, TFSHF and OMHE have similar daily volatility (0.00).Check OMHE's competition here
TFSHF vs RBII Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, RBII has a market cap of 499. Regarding current trading prices, TFSHF is priced at $1.50, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RBII's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to RBII's ROE of -0.04%. Regarding short-term risk, TFSHF and RBII have similar daily volatility (0.00).Check RBII's competition here
TFSHF vs ACGJ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, TFSHF is priced at $1.50, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to ACGJ's ROE of N/A. Regarding short-term risk, TFSHF and ACGJ have similar daily volatility (0.00).Check ACGJ's competition here
TFSHF vs MDVLQ Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, TFSHF is priced at $1.50, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, TFSHF is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check MDVLQ's competition here
TFSHF vs ISHI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, ISHI has a market cap of 5. Regarding current trading prices, TFSHF is priced at $1.50, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ISHI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to ISHI's ROE of N/A. Regarding short-term risk, TFSHF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check ISHI's competition here
TFSHF vs SYNI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, SYNI has a market cap of 3. Regarding current trading prices, TFSHF is priced at $1.50, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SYNI's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to SYNI's ROE of N/A. Regarding short-term risk, TFSHF and SYNI have similar daily volatility (0.00).Check SYNI's competition here
TFSHF vs GHTI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, GHTI has a market cap of 0. Regarding current trading prices, TFSHF is priced at $1.50, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GHTI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to GHTI's ROE of N/A. Regarding short-term risk, TFSHF is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.Check GHTI's competition here
TFSHF vs MDSI Comparison August 2025
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at 0. In comparison, MDSI has a market cap of 0. Regarding current trading prices, TFSHF is priced at $1.50, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MDSI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to MDSI's ROE of N/A. Regarding short-term risk, TFSHF and MDSI have similar daily volatility (0.00).Check MDSI's competition here